Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Thoracic and Cardiovascular Surgery|September 23, 2003
A new aortoventriculoplasty for prosthetic aortic valve replacementUlrik Hvass, Franck Baron, A Elsebaey
Therapeutics and Clinical Risk Management|February 27, 2019
Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopeniaTamer A Elbedewy, Mohamed A Elsebaey, Samah A Elshweikh, et al.
Journal of Blood Medicine|January 8, 2021
Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life ExperienceTamer A Elbedewy, Mohamed A Elsebaey, Reem A Elkholy, et al.
BMC Gastroenterology|February 6, 2019
Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trialMohamed A Elsebaey, Mohamed A Tawfik, Sherif Ezzat, et al.
British Journal of Biomedical Science|November 19, 2020
Long non-coding RNA EGFR-AS1 in colorectal cancer: potential role in tumorigenesis and survival via miRNA-133b sponge and EGFR/STAT3 axis regulationM M Atef, A I Amer, Y M Hafez, et al.
Gastroenterology Research and Practice|March 19, 2019
Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver CirrhosisMohamed A Elsebaey, Mohamed A Tawfik, Samah A Elshweikh, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 3, 2019
Galectin-3 as a prognostic biomarker for diabetic nephropathyHossam Hodeib, Maha M Hagras, Dina Abdelhai, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|February 3, 2021
Sofosbuvir/Ledipasvir for Treatment of Chronic Hepatitis C Infection in Adult Patients with β- Thalassemia Major: A Real-Life StudyTamer A Elbedewy, Sherief Abd-Elsalam, Sahar Mohamed Mostafa, et al.
Infectious Disorders Drug Targets|December 21, 2018
Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 InfectionOssama A Ahmed, Mohamed A Elsebaey, Mohamed Hassan A Fouad, et al.
Infection and Drug Resistance|April 10, 2018
Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infectionOssama A Ahmed, Mohamed A Elsebaey, Mohamed Hassan A Fouad, et al.
Pageof 2